Skip to main content
. 2020 Mar 27;9(11):3656–3667. doi: 10.1002/cam4.2991

Figure 2.

Figure 2

A, Detailed characteristics of patients with PR. PR, partial response; SS, synovial sarcoma; MLS, myxoid liposarcoma; MCS, mesenchymal chondrosarcoma; LN, lymph node. Except Neoadjuvant/ adjuvant therapy. B., Swimmer plot of 9 PR patients treated with trabectedin. Horizontal line, dosing period; ■, progression; ▲, first response